Author

Davis Leitner

VLP Therapeutics (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Dhanya K. NambiariD· 1 shared Forrest Bowling· 1 shared Fred M. BaikiD· 1 shared Fumiya TaoiD· 1 shared Hongbin CaoiD· 1 shared Ivan Stephanek· 1 shared Jaya Sastri· 1 shared John B. SunwooiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Dhanya K. NambiarORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Alphavirus replicon particle expressing IL-12 reprograms tumor-associated macrophages and neutrophils and induces anti-tumor immunity

Momoko Ishikawa, Dhanya K. Nambiar, Jaya Sastri, Forrest Bowling, Keiko Ishimoto, Fumiya Tao, Koyo Takahashi, Ivan Stephanek, Hongbin Cao, Davis Leitner, Kenta Matsuda, Fred M. Baik, John B. Sunwoo, Quynh‐Thu Le, Jonathan Smith, Wataru Akahata

This study uses an alphavirus replicon particle expressing IL-12 to reprogram immunosuppressive tumor-associated macrophages and neutrophils, enhancing anti-tumor immunity and reducing tumor growth in mouse models.

bioRxiv · Aug 7, 2025 · PreprintCancer Biology